Renal Sympathetic Denervation and Insulin Sensitivity (RENSYMPIS Study)
NCT ID: NCT01785732
Last Updated: 2013-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2013-01-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of RENSYMPIS is to study the effects of renal denervation on:
1. Cardiovascular function
2. Metabolic factors
3. Inflammatory and endocrine factors
4. Coagulation
5. Sleep
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity
NCT01888315
RDN Fesibility Study
NCT05743894
Mindfulness in Chronic Kidney Disease
NCT04099992
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
NCT06927024
Pain Reduction Using NEurostimulation Study
NCT05311956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Renal denervation
Patients are randomized to renal denervation
Renal Denervation
Sympathetic renal denervation via renal arteries
Optimization of medical therapy
Antihypertensive treatment is optimized
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renal Denervation
Sympathetic renal denervation via renal arteries
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 30- 69 years
* Written informed consent
Exclusion Criteria
* Pseudohypertension
* Pregnancy
* Renal insufficiency (GFR \<45ml/min)
* Clinically significant stenotic valvular disease
* Oral anticoagulation
* CCS III-IV symptoms or CABG/PCI in previous 6 months
* Prior stroke
* Contrast agent allergy
* inappropriate renal artery anatomy (\< 4mm diameter, \< 20mm length)
30 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hospital District of Satakunta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Satakunta Central Hospital
Pori, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SA-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.